Gliatamin for low mood in adults with type 2 diabetes
Part of Hormones & metabolism, Mental health clinical trials.
This trial tests whether gliatamin (choline alphoscerate) can improve depressive mood in people with type 2 diabetes. You may be eligible if your diabetes is fairly controlled and your depression symptoms are in a mild-to-moderate range.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have type 2 diabetes (not type 1, not gestational diabetes, not secondary diabetes)
- You are age 50 or older
- Your blood sugar average is not extremely high (HbA1c 10% or lower)
- Your depression score is below 30 but not very low (Beck Depression Inventory between 10 and 29)
- You can safely use contraception if you could become pregnant
- You agree in writing after learning the study, alternatives, and risks
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if personalized messages sent through a smartphone app can help improve blood sugar control and mood in people with type 1 diabetes.
This Phase 2 trial tests whether an SGLT2 medicine (like empagliflozin) can reduce symptoms of major depression. It may help people with moderate-to-severe depression who are otherwise eligible for the study.
This trial tests if berberine, a natural compound, can improve both blood sugar and mood in people who have type 2 diabetes and major depression. It aims to understand how berberine works at a molecular level.
This trial tests a new medication called BGM0504 for people with type 2 diabetes that is not well managed with diet and exercise alone. It aims to see if the drug can help lower blood sugar levels.
This trial tests a group program that helps people with type 2 diabetes manage diabetes-related distress and improve blood sugar levels (A1c). It's for adults who feel stressed or overwhelmed by their diabetes and want to learn emotion-focused coping skills.
This study tests whether a weekly injection of semaglutide (a medication used for weight loss and diabetes) can help reduce symptoms of depression in people who have major depressive disorder and are overweight or obese.
Hear when a new Type2 Diabetes With Depressive Mood trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.